AchieveRx Quit Co
AchieveRx Quit Co (ACHV) Implied Volatility Current
ACHV's 30 day implied volatility is 84.06%, with an IV Rank of 18.65%. This is a low IV Rank versus the past year, meaning AchieveRx Quit Co options are relatively cheap and currently favor buyers. ACHV's 30 day historical volatility sits at 62.14%, which means implied volatility is running 21.92 points above historical volatility, as of Nov 16, 2026.
Read more
Tracking ACHV implied volatility helps you spot when AchieveRx Quit Co options are historically cheap or expensive, and where the best trades are hiding. When ACHV IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor ACHV implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking ACHV IV rank helps you see whether ACHV's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Implied Volatility
IV is subdued. Premiums are cheap, favoring buyers.
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →